2型糖尿病患者微量白蛋白尿的降低：滋贺微量白蛋白尿降低试验（SMART） - Suppr

Suppr

超能文献

Reduction of microalbuminuria in patients with type 2 diabetes: the Shiga Microalbuminuria Reduction Trial (SMART).

作者信息

Uzu Takashi, Sawaguchi Makoto, Maegawa Hiroshi, Kashiwagi Atsunori

机构信息

Shiga University of Medical Science, Seta, Otsu, Japan.

出版信息

Diabetes Care. 2007 Jun;30(6):1581-3. doi: 10.2337/dc06-2493. Epub 2007 Mar 15.

DOI:10.2337/dc06-2493

PMID:17363751

Abstract

摘要

相似文献

Reduction of microalbuminuria in patients with type 2 diabetes: the Shiga Microalbuminuria Reduction Trial (SMART).

Diabetes Care. 2007 Jun;30(6):1581-3. doi: 10.2337/dc06-2493. Epub 2007 Mar 15.

Impact of renin-angiotensin system inhibition on microalbuminuria in type 2 diabetes: a post hoc analysis of the Shiga Microalbuminuria Reduction Trial (SMART).

Hypertens Res. 2008 Jun;31(6):1171-6. doi: 10.1291/hypres.31.1171.

[The Shiga Microalbuminuria Reduction Trial].

Nihon Rinsho. 2010 Nov;68 Suppl 9:445-50.

[Valsartan in patients with arterial hypertension and type 2 diabetes mellitus. The lapaval study].

Nefrologia. 2005;25(5):500-8.

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.

J Hypertens. 2006 Jul;24(7):1405-12. doi: 10.1097/01.hjh.0000234122.55895.5b.

Prevention of microalbuminuria in patients with type 2 diabetes and hypertension.

J Hypertens. 2012 Apr;30(4):811-8; discussion 818. doi: 10.1097/HJH.0b013e328351856d.

[VALUE study underscores the significance of reaching aimed blood pressure values for minimizing cardiovascular risks].

Praxis (Bern 1994). 2004 Oct 13;93(42):1748.

Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.

Am J Hypertens. 2006 Dec;19(12):1241-8. doi: 10.1016/j.amjhyper.2006.05.011.

Regression of cardiac hypertrophy in type 2 diabetes with hypertension by candesartan.

Diabetes Res Clin Pract. 2006 Oct;74(1):8-14. doi: 10.1016/j.diabres.2006.03.032. Epub 2006 May 23.

Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.

Clin Ther. 2005 May;27(5):578-87. doi: 10.1016/j.clinthera.2005.05.006.

引用本文的文献

Association Between COVID-19 and Diabetes Management Indices in Japanese Type 2 Diabetes Mellitus Patients: A Single-Center, Retrospective Study.

Infect Drug Resist. 2024 Aug 29;17:3759-3767. doi: 10.2147/IDR.S475917. eCollection 2024.

Characteristics and Distribution of Scholarship Donations From Pharmaceutical Companies to Japanese Healthcare Institutions in 2017: A Cross-sectional Analysis.

Int J Health Policy Manag. 2023;12:7621. doi: 10.34172/ijhpm.2023.7621. Epub 2023 Aug 21.

Aldosterone-to-Renin Ratio Is Associated with Diabetic Nephropathy in Type 2 Diabetic Patients: A Single-Center Retrospective Study.

Med Sci Monit. 2022 Mar 20;28:e935615. doi: 10.12659/MSM.935615.

Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan.

JAMA Netw Open. 2019 May 3;2(5):e193817. doi: 10.1001/jamanetworkopen.2019.3817.

Non-steroidal anti-inflammatory drugs induce severe hematologic toxicities in lung cancer patients receiving pemetrexed plus carboplatin: A retrospective cohort study.

PLoS One. 2017 Feb 3;12(2):e0171066. doi: 10.1371/journal.pone.0171066. eCollection 2017.

Beneficial effect of calcium channel blockers on home blood pressure variability in the morning in patients with type 2 diabetes.

J Diabetes Investig. 2013 Jul 8;4(4):399-404. doi: 10.1111/jdi.12052. Epub 2013 Mar 4.

Therapeutic management of diabetic kidney disease.

J Diabetes Investig. 2011 Aug 2;2(4):248-54. doi: 10.1111/j.2040-1124.2011.00112.x.

Effects of blood pressure and the renin-angiotensin system on platelet activation in type 2 diabetes.

J Diabetes Investig. 2010 Oct 19;1(5):196-201. doi: 10.1111/j.2040-1124.2010.00048.x.

Renoprotective effects of telmisartan after unilateral renal ablation in rats.

Int J Nephrol Renovasc Dis. 2013 Oct 10;6:207-14. doi: 10.2147/IJNRD.S51216. eCollection 2013.

Effects of dual blockade of the renin-angiotensin system on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy and hypertension in the ORIENT: a post-hoc analysis (ORIENT-Hypertension).

Hypertens Res. 2013 Dec;36(12):1051-9. doi: 10.1038/hr.2013.86. Epub 2013 Sep 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验